Rabeprazole 20mg + Domperidone 30mg SR Cap

Indication

Domperidone and Rabeprazole, marketed as Raybenz DSR combine rabeprazole 20mg and domperidone 30mg SR in a gastro-resistant and sustained-release formulation. This medication duo is specifically tailored for treating gastroesophageal reflux disease (GERD) and peptic ulcer disease.

Domperidone functions as a prokinetic agent, enhancing gastrointestinal motility to facilitate smoother movement of food through the stomach and intestines. This action reduces symptoms like bloating and nausea, and minimizes acid reflux by expediting gastric emptying.

Rabeprazole, a proton pump inhibitor (PPI), complements Domperidone’s effects by reducing stomach acid production. By inhibiting the enzyme responsible for acid secretion, Rabeprazole decreases stomach acidity. This reduction is crucial in alleviating acid-related indigestion, heartburn, and promoting ulcer healing.

Raybenz DSR offers a synergistic approach to managing digestive disorders by addressing both motility and acid production. This combination provides effective symptom relief while supporting the long-term management of chronic gastrointestinal conditions, helping promote better digestive health and overall comfort.

Contraindication

Cough, Headache, Diarrhoea, Dizziness, Inflammation of the nose, abdominal pain, Vomiting, Weakness, Insomnia (difficulty in sleeping), Nausea, Constipation, Flatulence, Back pain, Pharyngitis.

Storage

Cool & Dry Place

Dosage

As directed by a Medical Practitioner or Physician.